Literature DB >> 22433973

Clinicopathological features of serrated adenocarcinoma defined by Mäkinen in dukes' B colorectal carcinoma.

Yosuke Shida1, Takahiro Fujimori, Hiroyuki Tanaka, Yukari Fujimori, Ryusuke Kimura, Hirofumi Ueda, Kazuhito Ichikawa, Shigeki Tomita, Hitoshi Nagata, Keiichi Kubota, Masahiro Tsubaki, Hiroyuki Kato, Takashi Yao, Tamotsu Sugai, Kenichi Sugihara, Yasuo Ohkura, Johji Imura.   

Abstract

OBJECTIVE: Serrated adenocarcinoma (SAC), proposed as a new pathologic type, arises predominantly in the right side of the colon and has a poorer prognosis than conventional colorectal carcinoma. The prognosis of colorectal carcinoma is variable in Dukes' B, so the aim of this study was to determine whether or not SAC has a poor prognosis in Dukes' B.
METHODS: The study group comprised 64 patients who underwent surgery for colorectal carcinoma. We undertook a statistical analysis of the association of SAC and non-SAC with sex, age, histologic type, depth of tumor, location of tumor, venous invasion and lymphatic invasion.
RESULTS: SACs were encountered in 17.5% of cases (n = 11). SAC had a less favorable 5-year survival than non-SAC (p = 0.0396 log-rank, Kaplan-Meier). The factors that achieved statistical significance in the univariate analysis were subsequently included in a multivariate analysis and we found that SAC was an independent factor (p = 0.027).
CONCLUSIONS: SAC has a poor prognosis and is not affected by other factors confirming that SAC is an independently less favorable prognostic factor.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22433973     DOI: 10.1159/000334837

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  8 in total

1.  Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients.

Authors:  Jeong Mo Bae; Tae Hun Lee; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Expression of the Serrated Markers Annexin A10 or Gremlin1 in Colonic Adenocarcinomas: Morphology and Prognostic Values.

Authors:  Benjamin Marquet; Aude Marchal Bressenot; Caroline Fichel; Nicole Bouland; Coralie Barbe; Olivier Bouché; Reza Kianmanesh; Marie-Danièle Diebold; Camille Boulagnon-Rombi
Journal:  Pathol Oncol Res       Date:  2020-06-24       Impact factor: 3.201

3.  High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma.

Authors:  Elmira Gheytanchi; Leili Saeednejad Zanjani; Roya Ghods; Maryam Abolhasani; Marzieh Shahin; Somayeh Vafaei; Marzieh Naseri; Fahimeh Fattahi; Zahra Madjd
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-22       Impact factor: 4.553

4.  Differentiation between sessile serrated adenoma/polyp and non-sessile serrated adenoma/polyp in large hyper plastic polyp: A Japanese collaborative study.

Authors:  Yosuke Shida; Kazuhito Ichikawa; Takahiro Fujimori; Yukari Fujimori; Shigeki Tomita; Takahiro Fujii; Yasushi Sano; Yasushi Oda; Hideyo Goto; Akihiko Ohta; Shinji Tanaka; Tamotsu Sugai; Takashi Yao; Yasuo Ohkura; Johji Imura; Hiroyuki Kato
Journal:  Mol Clin Oncol       Date:  2012-09-07

Review 5.  Prognostic stratification of colorectal cancer patients: current perspectives.

Authors:  Nora I Schneider; Cord Langner
Journal:  Cancer Manag Res       Date:  2014-07-02       Impact factor: 3.989

6.  Invasive mucinous adenocarcinoma associated with adjacent sessile serrated lesion of the appendix vermiform: a case report.

Authors:  Osamu Kinoshita; Yasutoshi Murayama; Yoshiaki Kuriu; Masayoshi Nakanishi; Chohei Sakakura; Eigo Otsuji
Journal:  Case Rep Pathol       Date:  2014-07-09

7.  Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival.

Authors:  Chung-Ta Lee; Yu-Chuan Huang; Liang-Yi Hung; Nan-Haw Chow; Pei-Fang Su; Chung-Liang Ho; Hung-Wen Tsai; Yi-Lin Chen; Shao-Chieh Lin; Bo-Wen Lin; Peng-Chan Lin; Jenq-Chang Lee
Journal:  Oncotarget       Date:  2017-05-23

8.  Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes.

Authors:  Daiki Hirano; Yuji Urabe; Shinji Tanaka; Koki Nakamura; Yuki Ninomiya; Ryo Yuge; Ryohei Hayashi; Shiro Oka; Yasuhiko Kitadai; Fumio Shimamoto; Koji Arihiro; Kazuaki Chayama
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.